The Europe Nanotechnology Market would witness market growth of 32.0% CAGR during the forecast period (2023-2030).
Nanotechnology represents a range of technologies performed on a nanometer scale with widespread applications in various industries. Nanotechnology-based diagnostic techniques currently under development may provide two significant benefits: detecting disease at an earlier stage and instant treatment facilities. Multiple innovations are being carried out in medical diagnosis to bring efficiency.
Nanoscale materials and devices are used in diagnostic tools, such as biosensors, for early disease detection. Nanotechnology is applied to develop innovative therapies, including cancer treatments, imaging agents, and tissue engineering. It creates cosmetics with enhanced properties, such as better sunscreen coverage and smoother textures. These are just a few examples of the diverse applications of nanotechnology. The field continues to evolve, with ongoing research and development opening new possibilities across various industries.
According to the government of the United Kingdom, total current healthcare expenditures in the UK in 2020 amounted to £257.6 billion, or £3,840 per person. The UK contributed 12.0% of the GDP in 2020, compared with 9.9% in 2019. In 2020, government-funded healthcare expenditures totaled £213,4 billion, grew by 14.9% in real terms, and accounted for approximately 83% of total healthcare expenditures. The rising healthcare expenditure in the United Kingdom has contributed to the growth of the market, particularly in healthcare and medical applications. The increased investment in healthcare has created opportunities to develop innovative nanotechnology-based solutions to improve patient care, diagnostics, and treatment.
The Germany market dominated the Europe Nanotechnology Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,014.4 million by 2030. The UK market is experiencing a CAGR of 30.9% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 33% during (2023 - 2030).
Based on Type, the market is segmented into Nanodevice, and Nanosensor. Based on Application, the market is segmented into Healthcare & Pharmaceuticals, Electronics & Semiconductor, Biotechnology, Chemicals & Advanced Materials, Automobiles, Aerospace, IT & Telecom, Textile, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujitsu Limited, Bruker Corporation, Thermo Fisher Scientific, Inc., Bayer AG, Infineon Technologies AG, Advanced Nano Products Co., Ltd (ANP CORPORATION), Kleindiek Nanotechnik GmbH, Altair Nanotechnologies Inc. (YinLong Group), Nanonics Imaging Ltd, eSpin Technologies, Inc.
Nanotechnology represents a range of technologies performed on a nanometer scale with widespread applications in various industries. Nanotechnology-based diagnostic techniques currently under development may provide two significant benefits: detecting disease at an earlier stage and instant treatment facilities. Multiple innovations are being carried out in medical diagnosis to bring efficiency.
Nanoscale materials and devices are used in diagnostic tools, such as biosensors, for early disease detection. Nanotechnology is applied to develop innovative therapies, including cancer treatments, imaging agents, and tissue engineering. It creates cosmetics with enhanced properties, such as better sunscreen coverage and smoother textures. These are just a few examples of the diverse applications of nanotechnology. The field continues to evolve, with ongoing research and development opening new possibilities across various industries.
According to the government of the United Kingdom, total current healthcare expenditures in the UK in 2020 amounted to £257.6 billion, or £3,840 per person. The UK contributed 12.0% of the GDP in 2020, compared with 9.9% in 2019. In 2020, government-funded healthcare expenditures totaled £213,4 billion, grew by 14.9% in real terms, and accounted for approximately 83% of total healthcare expenditures. The rising healthcare expenditure in the United Kingdom has contributed to the growth of the market, particularly in healthcare and medical applications. The increased investment in healthcare has created opportunities to develop innovative nanotechnology-based solutions to improve patient care, diagnostics, and treatment.
The Germany market dominated the Europe Nanotechnology Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $2,014.4 million by 2030. The UK market is experiencing a CAGR of 30.9% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 33% during (2023 - 2030).
Based on Type, the market is segmented into Nanodevice, and Nanosensor. Based on Application, the market is segmented into Healthcare & Pharmaceuticals, Electronics & Semiconductor, Biotechnology, Chemicals & Advanced Materials, Automobiles, Aerospace, IT & Telecom, Textile, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujitsu Limited, Bruker Corporation, Thermo Fisher Scientific, Inc., Bayer AG, Infineon Technologies AG, Advanced Nano Products Co., Ltd (ANP CORPORATION), Kleindiek Nanotechnik GmbH, Altair Nanotechnologies Inc. (YinLong Group), Nanonics Imaging Ltd, eSpin Technologies, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type- Nanodevice
- Nanosensor
- Healthcare & Pharmaceuticals
- Electronics & Semiconductor
- Biotechnology
- Chemicals & Advanced Materials
- Automobiles
- Aerospace
- IT & Telecom
- Textile
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Fujitsu Limited
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Bayer AG
- Infineon Technologies AG
- Advanced Nano Products Co., Ltd (ANP CORPORATION)
- Kleindiek Nanotechnik GmbH
- Altair Nanotechnologies Inc. (YinLong Group)
- Nanonics Imaging Ltd
- eSpin Technologies, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 5. Europe Nanotechnology Market, By Type
Chapter 6. Europe Nanotechnology Market, By Application
Chapter 7. Europe Nanotechnology Market, By Country
Chapter 8. Company Profiles
Companies Mentioned
- Fujitsu Limited
- Bruker Corporation
- Thermo Fisher Scientific, Inc.
- Bayer AG
- Infineon Technologies AG
- Advanced Nano Products Co., Ltd (ANP CORPORATION)
- Kleindiek Nanotechnik GmbH
- Altair Nanotechnologies Inc. (YinLong Group)
- Nanonics Imaging Ltd
- eSpin Technologies, Inc.
Methodology
LOADING...